News

Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction

Results Demonstrate the Active Pharmaceutical Ingredient in Cardiol's Novel CRD-38 Formulation Attenuates Harmful Fat Distribution and Key Markers of Cardiac…

9 months ago

Defence Announces Peer-reviewed Publication of Its Preclinical Data on Accum(R) as an Anti-Cancer Molecule in the Journal of Cancer Science

Vancouver, British Columbia--(Newsfile Corp. - October 10, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"…

9 months ago

Berlin Cures takes next step in battle against Long COVID

Collaboration with Uniklinikum Erlangen as 5th German research centerBERLIN, GERMANY / ACCESSWIRE / October 10, 2023 / Berlin Cures, a…

9 months ago

Relief Therapeutics Announces that more than 400,000 of its ADRs are Currently Outstanding and that, as a Result, the Company has Achieved an Important NASDAQ Initial Listing Milestone

GENEVA, SWITZERLAND / ACCESSWIRE / October 10, 2023 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical…

9 months ago

IRLAB Signs Phase III Regulatory US Consultants to Support Preparation for Mesdopetam’s end-of-Phase 2 Meeting with the US FDA

GOTHENBURG, SWEDEN / ACCESSWIRE / October 10, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company…

9 months ago

iHealth to Offer Savings Up to 63% on Best Sellers During Amazon October Prime Big Deal Days

Featured Essential Healthcare Products Include Country's Preferred At-Home Covid TestSUNNYVALE, CA / ACCESSWIRE / October 10, 2023 / iHealth Labs,…

9 months ago

ProAssurance Announces Dates for Release of Third Quarter 2023 Results Release and Investor Teleconference

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE:PRA) will report results for the quarter ended September 30, 2023 after the close of normal…

9 months ago

Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023

ENGLEWOOD, CO / ACCESSWIRE / October 9, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a pharmaceutical company…

9 months ago

Is Nutrition the Answer to Long-COVID? A Clinical Trial Will Explore the Impacts of the Medical Food KetoCitra Together With a Low-Carbohydrate Diet

SANTA BARBARA, CA / ACCESSWIRE / October 9, 2023 / Santa Barbara Nutrients, Inc. is pleased to announce that our…

9 months ago

Healee Announces New CEO with Extensive Expertise in Healthcare Technology Leadership, AI and Data Science Research

Plamen Petrov, Ph.D. to debut at HLTH 2023 with Healee’s innovative patient access solutionGREAT NECK, N.Y.--(BUSINESS WIRE)--Healee has announced the…

9 months ago